What is Felix?
Founded in 2019 and headquartered in Toronto, Ontario, Felix operates as a comprehensive digital health platform. The company provides a seamless interface for users to consult with licensed Canadian physicians regarding lifestyle medications. Once a prescription is issued, the platform facilitates the delivery of medication through an automated, user-centric refill schedule. This model addresses critical inefficiencies in traditional healthcare delivery, offering a modern, tech-enabled solution for patients seeking accessible and reliable medical care. Felix's market position is defined by its commitment to patient convenience, regulatory compliance, and the integration of telehealth services with logistics.
How much funding has Felix raised?
Felix has raised a total of $21.3M across 2 funding rounds:
Series A
$7.9M
Series B
$13.4M
Series A (2021): $7.9M with participation from BrandProject, H Ventures, Whitecap Venture Partners, and Mantella Venture Partners
Series B (2023): $13.4M led by Whitecap Venture Partners, Mantella Venture Partners, Canadian Business Growth Fund, and BDC Capital Management
Key Investors in Felix
Whitecap Venture Partners
Whitecap Venture Partners is a Toronto-based early-stage venture capital fund that invests in high-growth companies across ICT, MedTech, and FoodTech sectors, providing deep operational and strategic expertise.
Mantella Venture Partners
Mantella Venture Partners is an investment firm focused on early-stage software companies, offering hands-on support in product development, marketing, and team building to help founders scale.
Canadian Business Growth Fund
The Canadian Business Growth Fund provides long-term, minority capital to privately-owned Canadian businesses, focusing on driving growth and expansion through collaborative partnerships.
What's next for Felix?
With the successful closure of its latest funding round, Felix is well-positioned to accelerate its growth strategy. The company is expected to focus on enhancing its digital infrastructure, potentially expanding its service offerings, and deepening its market penetration within the Canadian healthcare ecosystem. As the demand for virtual care continues to rise, Felix's ability to maintain a high-quality, automated patient experience will be central to its long-term success. The strategic backing from institutional investors provides the necessary runway to scale operations while maintaining the rigorous standards required in the MedTech industry. Future developments will likely center on optimizing the supply chain and broadening the scope of lifestyle health conditions addressed by the platform.
See full Felix company page
